• NanoInk (Skokie, Illinois), focused on the emerging field of nanometer-scale manufacturing and applications development, has appointed three senior executives. Jim Whittle has been named vice president, business development and joins NanoInk from AT Kearney, where he was a member of the Global Healthcare/Lifesciences sector team. Bruce Dudzik has been named senior director, business development for NanoInk. Previously Dudzik was at Affymetrix and has more than 25 years of experience in the microarray and bioscience industries. Tom Levesque has been named senior director, DPN global sales. Levesque joins NanoInk from Synova, with more than 25 years of experience in sales and marketing capital equipment.

David White, MD, has been named chief medical officer of Respironics (Murrysville, Pennsylvania), effective May 1. White currently is director of the Clinical Sleep Disorders Program at Brigham and Women's Hospital and a professor of sleep medicine at Harvard Medical School. Respironics develops products and programs that serve the sleep and respiratory markets.

John Howe has joined Sanarus Medical (Pleasanton, California), a developer of minimally invasive medical devices for diagnosing and treating breast disease, as chief operating officer and CFO. Howe most recently was CFO for Eunoe.